Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hanny Sawaf"'
Autor:
Alvin G. Kwon, Hanny Sawaf, Gilda Portalatin, Shruti Shettigar, Leal C. Herlitz, Tariq Shafi, Hong Liang, Adam Kabuka, Scott Cohen, Surafel K. Gebreselassie, Shane A. Bobart
Publikováno v:
Kidney Medicine, Vol 6, Iss 10, Pp 100889- (2024)
Rationale & Objectives: Diabetic kidney disease (DKD) is a significant complication of diabetes mellitus, often leading to kidney failure. The absence of well-defined factors prevents distinguishing DKD from non-diabetic kidney disease (non-DKD; alte
Externí odkaz:
https://doaj.org/article/2a068e0313994a20babd4c3e35ca73fa
Autor:
Sharmeen Sorathia, Aro Daniela Arockiam, Elio Haroun, Rishabh Khurana, Alexandra Hall, Meghann McCarthy, Rupal K. Shastri, Hanny Sawaf, Keith R. McCrae, Christine L. Jellis, Tom Kai Ming Wang
Publikováno v:
Clinical Case Reports, Vol 12, Iss 6, Pp n/a-n/a (2024)
Key Clinical Message Our case depicts a challenging diagnosis of catastrophic antiphospholipid syndrome in a young patient with a heterogenous presentation with extensive clinical course, a wide range of investigations, including multimodality imagin
Externí odkaz:
https://doaj.org/article/1ac10fbe77df44fd9c8c15c26d406529
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Diabetic kidney disease (DKD) is a complication of diabetes that can lead to kidney failure. Over the years, several drugs have been developed to combat this disease. In the early 90s, angiotensin blockade (ACEi and ARBs) was introduced, which revolu
Externí odkaz:
https://doaj.org/article/6e8784ee787b44ac876b1f7423155a78
Autor:
Hanny Sawaf, Tariku T Gudura, Sylvester Dorobisz, Dianne Sandy, Xiangling Wang, Shane A Bobart
Publikováno v:
International Journal of Nephrology and Renovascular Disease. 16:1-15
Publikováno v:
EMJ Nephrology. :102-113
Diabetic kidney disease (DKD) has been an immense burden on the healthcare system, and is the leading cause of end stage kidney disease worldwide. DKD involves various intersecting pathways that lead to progressive kidney damage. Due to its versatile
Publikováno v:
EMJ Nephrology. :76-83
Sodium–glucose co-transporter inhibitors (SGLT2i) have recently gained a lot of emphasis in their role in preventing progression of chronic kidney disease and helping with cardiac mortality. Various studies have proven the benefit of these medicati
Autor:
Shane A. Bobart, Gilda Portalatin, Hanny Sawaf, Shruti Shettigar, Astrid Carrion-Rodriguez, Hong Liang, Leal Herlitz, Surafel K. Gebreselassie
Publikováno v:
Kidney360
BACKGROUND: The kidney biopsy is the gold standard for diagnosing glomerular diseases. Large-scale, epidemiologic studies describing the prevalence of kidney diseases are lacking, especially in the United States. We aimed to determine the spectrum of
Publikováno v:
Multidisciplinary Experiences in Renal Replacement Therapy
Fabry disease is a rare X-linked lysosomal storage disorder due to mutations in the GLA gene causing complete or partial deficiency of the lysosomal enzyme alpha-galactosidase A (a-Gal A). This enzyme deficiency results in tissue accumulation of trih
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b8dc2ecc6050f1f372f4a895aa25209
https://doi.org/10.5772/intechopen.103799
https://doi.org/10.5772/intechopen.103799
Autor:
Hanny Sawaf, George Thomas, Jonathan J. Taliercio, Georges Nakhoul, Tushar J. Vachharajani, Ali Mehdi
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 378, p 378 (2022)
Journal of Clinical Medicine
Journal of Clinical Medicine
Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease (ESKD) in the United States. Risk factor modification, such as tight control of blood glucose, management of hypertension and hyperlipidemia, and the use of renin–an
Autor:
Joyce T, Yuan, Daniel J, Aires, Matthew, DaCunha, Kristen, Funk, Arlette, Habashi-Daniel, Sarah A, Moore, Anna, Heimes, Hanny, Sawaf, Garth R, Fraga
Publikováno v:
Cutis. 100(6)
Promotion in academic dermatology requires evidence of scholastic production. The h-index is a bibliometric measure that combines both volume and impact of scientific contributions. Its calculation better predicts future scientific success than do pu